The 7 Stages of ALS: How They Could Be Broken Down

Understanding ALS Progression: Why Stages Matter for Treatment Planning

How ALS progresses differently in every person and why a staged framework helps

ALS progression varies significantly from person to person -- some experience rapid decline over months while others live with the disease for many years. [1] On average, most people live 2 to 5 years after diagnosis, though about 20% survive beyond 5 years and roughly 5% live 20 years or more -- factors explored further in our [understanding ALS life expectancy](https://alsunited.org/blog/understanding-als-life-expectancy-a-comprehensive-guide/) guide. [2] Because there is no single ALS timeline, a staged framework gives you and your care team a structured way to track where the disease stands and how ALS treatments may need to adapt at each point. [2] Two systems are most widely used: King's clinical staging, which tracks anatomical spread across body regions, and the Milano-Torino (MiToS) system, which measures loss of key functions like mobility, swallowing, and breathing. [3]

The connection between disease stages and available treatment options

ALS stage directly affects which treatments are appropriate and how much benefit they can offer. Riluzole, the first FDA-approved ALS medication, was studied in patients within five years of symptom onset with relatively preserved lung function, making it the broadest treatment option across disease stages.[4] Edaravone -- explained in depth in our [complete guide to Radicava](https://alsunited.org/blog/radicava-a-complete-guide-to-its-purpose-and-value-for-als-patients) -- proved effective only in a narrower group: patients within two years of symptom onset, with lung function at 80% or above, and functional impairment across all four ALSFRS-R domains.[4] Knowing your current stage helps your care team identify which ALS treatments fall within their effective window -- and which supportive therapies should be added alongside them.[4]

Why early intervention at each stage can impact quality of life and outcomes

ALS treatments cannot restore function that has already been lost -- they can only slow the rate at which remaining function declines. [5] This makes timing critical: a person who begins treatment while they can still walk has a meaningful opportunity to preserve that ability longer, while waiting until mobility is severely compromised leaves little for any therapy to work with. [5] The same principle applies to supportive interventions like physical therapy, respiratory support, and nutritional care -- each delivers more benefit when introduced before a function deteriorates than after. [5] Despite this, the average gap between first symptoms and a confirmed diagnosis is roughly 12 months, delaying access to both medications and supportive care during what is often the most treatment-responsive window. [6]

The 7 Stages of ALS Explained: From Diagnosis Through Advanced Disease

Stage 1-2: Early onset and initial symptom management with disease-modifying medications

In Stages 1 and 2, symptoms typically appear in one body region -- such as [early hand weakness](https://alsunited.org/blog/early-stage-als-hand-symptoms-what-to-look-for), foot drop, or changes in speech -- while motor function elsewhere remains largely intact. [7] This is the window when all three FDA-approved disease-modifying therapies are most applicable: riluzole (approved 1995), edaravone (approved 2017), and tofersen (approved 2023, specifically for patients with a confirmed SOD1 gene mutation). [7] None of these medications cure ALS -- they aim to slow progression, which means starting them during Stages 1-2 gives them the most function to preserve. [7] If you're researching Relyvrio, it's no longer available: the manufacturer voluntarily withdrew it in 2024 after a Phase 3 trial showed it did not slow disease progression compared to placebo. [7]

Stage 3-4: Mid-progression and adapting treatments as mobility and function change

By Stage 3, weakness has spread to three or more body regions, and while most people can still walk, mobility is noticeably impaired -- stairs become difficult, gait grows unsteady, and fatigue becomes a consistent barrier to daily activity. [8] Stage 4 marks a clearer transition: a wheelchair becomes necessary for most distances, visible muscle wasting appears in affected limbs, and tasks like dressing and bathing require direct assistance. [8] At these stages, care planning extends well beyond medications -- [physical therapy](https://alsunited.org/blog/upper-body-physical-therapy-exercises-for-als), dietary adjustments for swallowing changes, home safety modifications, and augmentative communication tools all become active parts of a coordinated care plan. [1] Fall prevention and home accessibility assessments are especially important in Stage 4, when the risk of injury rises significantly alongside increasing dependence. [8]

Stage 5-7: Advanced disease and palliative care approaches to maintain comfort and dignity

Stages 5 through 7 mark a transition from significant dependence to full-time care, as most voluntary muscles -- including those controlling breathing, speaking, and swallowing -- become progressively paralyzed. [1] Respiratory decline accelerates during these stages, bringing fatigue, headaches, and increased susceptibility to pneumonia, with mechanical ventilation becoming necessary for many people. [2] The focus of care shifts toward comfort and dignity: palliative care teams work alongside neurologists to manage pain, anxiety, and respiratory distress while guiding decisions about ventilation and feeding. [9] Research shows that people with ALS who receive palliative care have improved survival compared to those receiving only general neurology care -- making early referral a meaningful clinical decision, not a last resort. [9]

ALS Treatments Across All Stages: What Medications and Therapies Are Available

FDA-approved medications that can slow progression in early and mid-stage ALS

Three FDA-approved medications target ALS progression through distinct mechanisms -- a detailed breakdown is available in our [guide to ALS medication mechanisms](https://alsunited.org/blog/mechanisms-of-als-medications). Riluzole reduces glutamate-related nerve toxicity, and real-world data shows it can extend median survival by 6 to 19 months compared to untreated patients, though it requires regular liver enzyme monitoring throughout use. [10] Edaravone combats oxidative stress and slows functional decline by roughly 33% in eligible patients, delivered on a 14-day-on, 14-day-off dosing schedule available in both IV and oral form. [7] Tofersen takes the most targeted approach, using an antisense oligonucleotide to reduce SOD1 protein levels -- genetic testing for the SOD1 mutation must confirm eligibility before treatment can begin. [7]

Therapeutic interventions, respiratory support, and symptom management at each stage

Supportive therapies run alongside medications at every stage, shifting in type and intensity as the disease advances. Respiratory monitoring begins early -- FVC testing tracks lung function over time, and non-invasive ventilation (NIV) is introduced when breathing symptoms appear, starting at four hours per night and progressing to full-night use. [11] Speech-language pathologists assess both swallowing and communication at regular intervals, and augmentative devices should be evaluated before speech becomes severely impaired -- especially in [bulbar-onset ALS](https://alsunited.org/blog/understanding-bulbar-als), where these symptoms arrive first. [12] In later stages, cough-assist machines help clear mucus from weakened airways, and palliative measures like low-dose morphine for breathlessness and lorazepam for anxiety manage respiratory distress without hastening death. [11]

Choosing the right treatment approach: How ALS United's medical resources guide your decisions

Navigating ALS treatment decisions is more manageable when you have structured decision-support tools built specifically for people living with the disease. The My ALS Decision Tool(TM), developed by an ALS United member organization, guides you through high-stakes choices -- from invasive mechanical ventilation to genetic testing and clinical trial participation -- using language informed by health literacy best practices. [13] Each module was developed with input from people living with ALS, caregivers, and multidisciplinary clinicians including nurses and social workers with decades of direct ALS consultation experience. [13] After completing a module, you're prepared to have a grounded, specific conversation with your care team rather than approaching those decisions without context. [13]

Building Your Personalized ALS Care Plan: Using Stages to Navigate Support and Advocacy

How to work with your healthcare team to align treatments with your current stage

Working with your ALS care team effectively means communicating specifically about where your disease currently stands, not just reporting symptoms -- [understanding the specialists involved](https://alsunited.org/blog/what-type-of-doctor-treats-als-understanding-als-medical-care) helps you know who to direct each concern to. Evidence-based guidelines recommend multidisciplinary clinic reviews every two to three months, with the team tracking changes across mobility, speech, swallowing, and breathing to determine when ALS treatments need to be adjusted or added. [14] Multidisciplinary clinics coordinating neurology, respiratory care, nutrition, and social work have been shown to reduce one-year mortality by 30% and cut hospitalizations -- outcomes general neurology care alone doesn't replicate. [15] Before each appointment, noting specific functional changes since your last visit gives your team the clinical signal they need to update your care plan before a function deteriorates further. [14]

Accessing ALS United's clinic finder, counseling, and community support at every progression point

Our clinic finder connects you to ALS multidisciplinary clinics where neurology, respiratory care, nutrition, and social work coordinate under one appointment -- reducing the burden of managing specialists independently across separate visits. [16] Member organizations in our network offer free services including professional care managers, equipment loan programs, and [community support groups](https://alsunited.org/blog/join-a-support-group) for people with ALS and their families, available regardless of insurance or immigration status. [17] Topic-specific connection groups, educational webinars, and bereavement support extend care beyond the clinic -- giving you, your caregivers, and your family consistent resources at every stage of disease progression. [17] Together in the fight, the network spans clinical expertise, community connection, and trusted educational tools so no one navigates ALS without support. [18]

Planning ahead: Resources for caregivers and families as ALS stages advance

As ALS advances, caregiving typically shifts to round-the-clock responsibilities -- feeding, hygiene, respiratory support, and mobility transfers -- that no single person can manage alone. [19] Building a care network before full dependence arrives gives you time to arrange paid aides, apply for Medicaid or VA caregiver benefits, and determine whether home hospice is appropriate, which is often earlier in the disease than families expect. [19] The VA Caregiver Support Line (1-855-260-3274) connects eligible caregivers to federal assistance and local coordination support, while our [Medicare and home health resources](https://alsunited.org/blog/medicare-and-home-health-information) outline insurance options across every disease stage. [20] Scheduling regular respite time -- through formal aide coverage or trusted friends -- protects against burnout, and caregivers who take consistent breaks are better positioned to sustain the level of care their loved one needs over time. [19]